Title of article :
Gustav III’s risk assessment on coffee consumption; A medical history report
Author/Authors :
Afshari, Reza Environmental Health Services - BC Centre for Disease Control - Canada
Pages :
2
From page :
99
To page :
100
Abstract :
Coffee is one of the most commonly consumed drinks worldwide. For centuries, medicinal values and potential toxic effects related to coffee have been discussed. Consumption of coffee was not always welcome by physicians. However, it has been shown that even physicians commonly drink coffee as a stimulant (Giesinger et al., 2015). Recently, meta-analyses revealed that drinking coffee induces a dosedependent risk reduction after acute myocardial infarction (Brown et al., 2016). In addition, more positive reports on drinking coffee are being published including 2016 surprising announcement by the Agency for Research on Cancer (IARC) (Brown al., 2016) to discard its own previous report on cancerogenicity of coffee drinking in humans (IARC, 1991; Loomis et al., 2016). If coffee decreases the possibility of myocardial infarction and it is no longer harmful from a carcinogenicity point of view, it is the time to acknowledge Gustav III (1746- 1792 CE) (Encyclopædia Britannica, 2016), the adventures king of Sweden’s, pioneer experiment on coffee safety as the first documented “randomized clinical trial” in medical history. In the same year that he was born, the “Misuse and Excesses Tea and Coffee Drinking Edict” was signed by his father, Adolph Frederick, and taxes were implemented on use with heavy fines and confiscation of cups and dishes for coffee drinkers if they do not confess they used this psychoactive intoxicant (Weinberg and Bealer, 2001). Later, a total ban was implemented in the country
Keywords :
Coffee , Heart , medical history
Journal title :
Avicenna Journal of Phytomedicine AJP)
Serial Year :
2017
Record number :
2514704
Link To Document :
بازگشت